Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement

Annals of Internal Medicine

Volumn 161, Issue 12, 2014, Pages 902-910

  LeFevre, Michael L ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTRACEPTION; COST OF ILLNESS; ETHNIC DIFFERENCE; GEOGRAPHY; GONORRHEA; HUMAN; INFECTION RISK; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PATIENT COUNSELING; PREGNANT WOMAN; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SCREENING; SEXUAL BEHAVIOR; THROAT CULTURE; UNITED STATES; UNSAFE SEX; URINALYSIS; ADOLESCENT; ADULT; ASYMPTOMATIC DISEASE; CHLAMYDIA INFECTIONS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE COST; MALE; MASS SCREENING; MEDICAL RESEARCH; MICROBIOLOGICAL EXAMINATION; PRACTICE GUIDELINE; PREGNANCY; YOUNG ADULT;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ASYMPTOMATIC DISEASES; BACTERIOLOGICAL TECHNIQUES; BIOMEDICAL RESEARCH; CHLAMYDIA INFECTIONS; EARLY DIAGNOSIS; FEMALE; GONORRHEA; HEALTH CARE COSTS; HUMANS; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREGNANCY; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84907456352     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-1981     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. 2012 Sexually Transmitted Diseases Surveillance. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at www.cdc.gov/std/stats12/default.htm on 12 August 2014.
2. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;291:2229-36. [PMID: 15138245]
3. Centers for Disease Control and Prevention. Gonorrhea - CDC Fact Sheet (Detailed Version). Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea-detailed.htm on 12 August 2014.
4. Baeten JM, Overbaugh J. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res. 2003;1:69-86. [PMID: 15043213]
5. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28:579-97. [PMID: 11689757]
6. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63:1-19. [PMID: 24622331]
7. Nelson HD, Zakher B, Cantor A, Daeges M, Pappas M. Screening for Gonorrhea and Chlamydia: Systematic Review to Update the U.S. Preventive Services Task Force Recommendations. Evidence synthesis no. 115. AHRQ publication no. 13-05184-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
8. Centers for Disease Control and Prevention. Reported STDs in the United States: 2012 National Data for Chlamydia, Gonorrhea, and Syphilis. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at www.cdc.gov/nchhstp/newsroom/docs/STD-Trends-508.pdf on 14 August 2014.
9. Owusu-Edusei K Jr, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40:197-201. [PMID: 23403600] doi:10.1097/OLQ.0b013e318285c6d2
10. Tao G, Irwin KL. Receipt of HIV and STD testing services during routine general medical or gynecological examinations: variations by patient sexual risk behaviors. Sex Transm Dis. 2008;35:167-71. [PMID: 18090177]
11. Zakher B, Cantor AG, Pappas M, Daeges M, Nelson HD. Screening for gonorrhea and chlamydia: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;161:XXX-XXX. doi:10.7326/M14-1022
12. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med. 2001;20:95-107. [PMID: 11306238]
13. Glass N, Nelson HD, Villemyer K. Screening for Gonorrhea: Update of the Evidence for the U.S. Preventive Services Task Force. AHRQ publication no. 05-0579-B. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
14. Meyers DS, Halvorson H, Luckhaupt S. Screening for Chlamydial Infection: A Focused Evidence Update for the U.S. Preventive Services Task Force. Evidence synthesis no. 48. AHRQ publication no. 07-05101-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
15. Chernesky MA, Martin DH, Hook EW, Willis D, Jordan J, Wang S, et al. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol. 2005;43:127-31. [PMID: 15634960]
16. Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, et al CT/NG Study Group. Performance of the Cepheid CT/NG Xpert Rapid PCR Test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013;51:1666-72. [PMID: 23467600] doi:10.1128/JCM.03461-12
17. Schachter J, McCormack WM, Chernesky MA, Martin DH, Van Der Pol B, Rice PA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol. 2003;41:3784-9. [PMID: 12904390]
18. Shrier LA, Dean D, Klein E, Harter K, Rice PA. Limitations of screening tests for the detection of Chlamydia trachomatis in asymptomatic adolescent and young adult women. Am J Obstet Gynecol. 2004;190:654-62. [PMID: 15041995]
19. Taylor SN, Liesenfeld O, Lillis RA, Body BA, Nye M, Williams J, et al. Evaluation of the Roche Cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis. 2012;39:543-9. [PMID: 22706217] doi:10.1097/OLQ.0b013e31824e26ff
20. Taylor SN, Van Der Pol B, Lillis R, Hook EW 3rd, Lebar W, Davis T, et al. Clinical evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis. 2011;38:603-9. [PMID: 21301389] doi:10.1097/OLQ.0b013e31820a94d2
21. Van Der Pol B, Liesenfeld O, Williams JA, Taylor SN, Lillis RA, Body BA, et al. Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2012;50:2244-9. [PMID: 22518864] doi: 10.1128/JCM.06481-11
22. Van Der Pol B, Taylor SN, Lebar W, Davis T, Fuller D, Mena L, et al. Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis. 2012;39:147-53. [PMID:22249304]doi:10.1097/OLQ.0b013e3182372fd8
23. Schoeman SA, Stewart CM, Booth RA, Smith SD, Wilcox MH, Wilson JD. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ. 2012;345:e8013. [PMID: 23236032] doi:10.1136/bmj.e8013
24. Stewart CM, Schoeman SA, Booth RA, Smith SD, Wilcox MH, Wilson JD. Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study. BMJ. 2012;345:e8107. [PMID: 23236033] doi:10.1136/bmj.e8107
25. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362-6. [PMID: 8614421]
26. Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis. 2000;31:951-7. [PMID: 11049776]
27. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention of Pelvic Infection) trial. BMJ. 2010;340:c1642. [PMID: 20378636] doi:10.1136/bmj.c1642
28. U.S. Preventive Services Task Force. Screening for chlamydial infection-including ocular prophylaxis in newborns. In: Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2nd ed. Washington, DC: U.S. Department of Health and Human Services; 1996.
29. U.S. Preventive Services Task Force. Screening for gonorrhea-including ocular prophylaxis in newborns. In: Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2nd ed. Washington, DC: U.S. Department of Health and Human Services; 1996.
30. Ryan GM Jr, Abdella TN, McNeeley SG, Baselski VS, Drummond DE. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol. 1990;162:34-9. [PMID: 2301514]
31. Smith JR, Taylor-Robinson D. Infection due to Chlamydia trachomatis in pregnancy and the newborn. Baillieres Clin Obstet Gynaecol. 1993;7:237-55. [PMID: 8513644]
32. U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;147:128-34. [PMID: 17576996]
33. Centers for Disease Control and Prevention. Sexually Transmitted Diseases: Clinical Practice Guidelines. Atlanta, GA: Centers for Disease Control and Prevention; 1991.
34. Hook EI, Handsfield HH. Gonococcal infections in the adult. In: Sexually Transmitted Diseases. 2nd ed. New York: McGraw-Hill; 1990.
35. U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med. 2005;3:263-7. [PMID: 15928231]
36. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59:1-110. [PMID: 21160459]
37. Burstein G, Jacobs A, Kissin D, Workowski K. Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know. Washington, DC: American Congress of Obstetricians and Gynecologists; 2010. Accessed at, www.acog.org/About-ACOG/ACOG-Departments/Adolescent-Health-Care/Changes-in-the-2010STD-Treatment-Guidelines-What-Adolescent-Health-Care-Providers-Should-Know on 14 August 2014.
38. American Academy of Pediatrics Committee on Adolescence and Society for Adolescent Health and Medicine. Screening for nonviral sexually transmitted infections in adolescents and young adults. Pediatrics. 2014;134:e302-11.
39. American Academy of Family Physicians. Clinical Preventive Services. Leawood, KS: American Academy of Family Physicians; 2014. Accessed at www.aafp.org/patient-care/clinical-recommendations/cps.html on 14 August 2014.
40. Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. Ottawa, Ontario, Canada: Public Health Agency of Canada; 2008. Accessed at, http://publications.gc.ca/collections/collection-2011/aspc-phac/HP40-1-2010-eng.pdf on 14 August 2014.